Bowen Acquisition Corp
BOWNU
NASDAQ Global Market13.02
USD
- -
- -
Bowen Acquisition Corp
BOWNU
(NASDAQ Global Market)
Recent
price
13.02
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Bowen Acquisition Corp is a Cayman Islands exempted special purpose acquisition company (SPAC) focused on effecting mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations. The company targets strategic acquisitions primarily in Asia, excluding entities with Chinese operations consolidated through variable interest entity (VIE) structures. Bowen Acquisition Corp does not produce or sell products directly but aims to identify and merge with high-potential businesses, thereby facilitating their transition to public markets. The SPAC was incorporated in 2023 and is headquartered in New York, New York. The company completed its initial public offering in July 2023, raising $60 million through the sale of 6 million units. Recent major developments include entering into a merger agreement with Shenzhen Qianzhi BioTech Company Ltd, positioning Bowen Acquisition Corp to expand in the biotechnology sector within China and Asia. It has also navigated regulatory challenges, including a Nasdaq delisting notice in mid-2025 due to listing requirements non-compliance, with ongoing efforts to appeal and maintain its trading status. Bowen Acquisition Corp continues to prioritize strategic business combinations to create shareholder value and expand its operational scope across dynamic Asian markets. As a SPAC, Bowen Acquisition Corp's core activities revolve around identifying prospective merger targets without limitation to a specific industry but with an initial focus on technology and biotechnology sectors. The company leverages its expertise in financial structuring and market access to support target companies' public listings and growth ambitions. Its operations are currently centered on merger and acquisition transactions rather than direct service or product manufacturing, reflecting its role as a financial intermediary in the capital markets. Bowen Acquisition Corp conducts its business from its New York headquarters, serving a global investor base interested in high-growth Asian enterprises.
Bowen Acquisition Corp Receives NASDAQ Delisting Notification for Failure to Comply with Listing Requirements
Bowen Acquisition Corp Receives NASDAQ Notification of Non-Compliance with Listing Rules
Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company
Bowen Acquisition Corp Announces Separate Trading of its Ordinary Shares and Rights
Bowen Acquisition Corp Announces Closing of Full Over-Allotment Option
Bowen Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering
Bowen Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering